State Street offers a high-dividend version of its S&P 500 ETF, SPYD, which focuses on high-yield stocks and pays larger quarterly dividends than the traditional SPY ETF. SPYD holds more real estate, utilities, and energy stocks, resulting in higher income but lower growth and sensitivity to interest rates. While SPYD charges a slightly lower fee and suits income-focused investors, SPY remains better for growth and reinvestment over the long term. Investors should consider tax implications and their income needs before switching.
The story on State Street's high-dividend S&P 500 ETF, SPYD, is presented here with Pluang's market data as context. For readers following US stocks on Pluang as of Sep 30, 2026 05:21 WIB, out of 150 priced stocks, 68 rose and 82 fell. Notable movers include DraftKings Inc (DKNG) at USD 19.66 with a 1-day change of -7.09% and typical hold time of 55 days, AMC Entertainment Holdings (AMC) at USD 3.08 down 6.23% with a typical hold time of 87 days, and Applied Materials Inc (AMAT) at USD 513.61 up 5.52% with a typical hold time of 66 days.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
